Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
NANO Nuclear Energy Awarded AFWERX Direct to Phase II Contract for KRONOS MMR™ RDT&E at Joint Base Anacostia-Bolling
-
Enthusiast Gaming Completes Direct Sales Business Divestment
-
Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak
-
Digi Power X Expands Digital Asset Holdings and Accelerates Pivot to AI Infrastructure with Alabama Build-Out and Reports August 2025 Production Results
-
Glass Lewis Recommends Shareholders Vote FOR DallasNews’ Merger with Hearst
-
Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism
-
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
-
Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Dragonfly Energy Announces Updated Corporate Presentation
-
BridgeBio to Present Phase 2 Proof-of-Concept Data for Encaleret in Post-Surgical Hypoparathyroidism
-
Habit Burger & Grill Unveils Its New Sirloin Steak Sandwich
-
Bread Financial to Participate in the Barclays 23rd Annual Global Financial Services Conference
-
Codere Online Announces Chief Financial Officer Transition to New Role
-
Nexxen Announces August 2025 Share Repurchase Program Summary
-
K Wave Media Accelerates Growth with First Acquisition Post-Listing, a Visual Effects and AI-powered Advertising Company, Adds World-Class Tech Companies as New Clients
-
Alterity Therapeutics to Present at the Biotech Showcase
-
SubQuery Announces 100M $SQT Consumer Rewards Pool
-
SubQuery Announces 100M $SQT Consumer Rewards Pool
-
Hammond Power Solutions Provides Update on U.S. Tariff Changes
-
Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million
-
MGA Entertainment Unleashes Ninjombie™: Ninjas, Zombies, and Slime Collide in Explosive New Boys Action Franchise
-
Black Rock Coffee Bar Announces Launch of Initial Public Offering
-
Stabilization Notice - Pre Stab REXEL S.A
-
David Wyles Joins Perella Weinberg as Partner
-
Kraig Biocraft Laboratories' Lead Sericulture Expert Joins Recombinant Spider Silk Production Team at New Rearing Facility in Southeast Asia
-
Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million
-
Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025
-
Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025
-
Tutors Warn Time Management and Well-Being Are the Biggest Hurdles Students Face in New School Year
-
2025 CIFTIS: Beijing connects the world with digital intelligence
-
Couture Weaves a Story of Unity as Kruger Products Announces its Designer Roster for the 2025 Cashmere Collection
-
Mobix Labs Technology Cleared for Deployment Into US Navy Communications Systems
-
Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer
-
Forsys Reports Drilling Results from Norasa
-
Erdene Completes Share Consolidation
-
Fury Announces Results of Preliminary Economic Assessment for the Eau Claire Gold Deposit with a Base Case After-Tax NPV (5%) of $554M and After-Tax IRR of 41%
-
Gaming & Leisure Properties Furthers Tribal Partnership With Accretive Long-Term Financing for Caesars Republic Sonoma County
-
Neumora Therapeutics to Participate in Upcoming Conferences in September
-
Playboy to Participate in Lake Street’s Best Ideas Growth Conference
-
Skye Completes 26-week Treatment Phase in Phase 2a CBeyond™ Study
-
Sophos Endpoint Now Integrated with Taegis MDR and XDR, Strengthening Cybersecurity ROI
-
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
-
Saquon Barkley Partners with Wawa in a New Commercial to Celebrate Fans
-
Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treat
-
FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million
-
Kamada to Participate in Upcoming September Investor Conferences
-
AlloFlo™ Uveo Achieves Key Milestones Ahead of Launch: 7 Peer-Reviewed Studies & 3,000 U.S. Cases
-
Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
-
Coda Octopus Group Sets Fiscal Third Quarter 2025 Earnings Conference Call for Monday, September 15, 2025, at 10 a.m. Eastern Time
